These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 15916788)

  • 1. Sex- and dose-dependency in the pharmacokinetics and pharmacodynamics of (+)-methamphetamine and its metabolite (+)-amphetamine in rats.
    Milesi-Hallé A; Hendrickson HP; Laurenzana EM; Gentry WB; Owens SM
    Toxicol Appl Pharmacol; 2005 Dec; 209(3):203-13. PubMed ID: 15916788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous locomotor activity and pharmacokinetics of intravenous methamphetamine and its metabolite amphetamine in the rat.
    Rivière GJ; Byrnes KA; Gentry WB; Owens SM
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1220-6. PubMed ID: 10565845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of methamphetamine and its metabolite amphetamine in brain and other tissues in rats after intravenous administration.
    Rivière GJ; Gentry WB; Owens SM
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1042-7. PubMed ID: 10688621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (+)-Methamphetamine-induced spontaneous behavior in rats depends on route of (+)METH administration.
    Gentry WB; Ghafoor AU; Wessinger WD; Laurenzana EM; Hendrickson HP; Owens SM
    Pharmacol Biochem Behav; 2004 Dec; 79(4):751-60. PubMed ID: 15582684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficiency of an anti-(+)-methamphetamine monoclonal antibody in the protection against cardiovascular and central nervous system effects of (+)-methamphetamine in rats.
    Gentry WB; Laurenzana EM; Williams DK; West JR; Berg RJ; Terlea T; Owens SM
    Int Immunopharmacol; 2006 Jun; 6(6):968-77. PubMed ID: 16644483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge.
    O'Neil ML; Kuczenski R; Segal DS; Cho AK; Lacan G; Melega WP
    Synapse; 2006 Nov; 60(6):465-73. PubMed ID: 16897726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a liquid chromatography-tandem mass spectrometric method for the determination of methamphetamine and amphetamine using small volumes of rat serum.
    Hendrickson HP; Milesi-Hallé A; Laurenzana EM; Owens SM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jul; 806(2):81-7. PubMed ID: 15171915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization.
    Segal DS; Kuczenski R
    J Pharmacol Exp Ther; 1997 Aug; 282(2):561-73. PubMed ID: 9262316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gestation time-dependent pharmacokinetics of intravenous (+)-methamphetamine in rats.
    White S; Laurenzana E; Hendrickson H; Gentry WB; Owens SM
    Drug Metab Dispos; 2011 Sep; 39(9):1718-26. PubMed ID: 21632964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in methamphetamine pharmacokinetics in adult rats and its transfer to pups through the placental membrane and breast milk.
    Rambousek L; Kacer P; Syslova K; Bumba J; Bubenikova-Valesova V; Slamberova R
    Drug Alcohol Depend; 2014 Jun; 139():138-44. PubMed ID: 24726427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in (+)-amphetamine- and (+)-methamphetamine-induced behavioral response in male and female Sprague-Dawley rats.
    Milesi-Hallé A; McMillan DE; Laurenzana EM; Byrnes-Blake KA; Owens SM
    Pharmacol Biochem Behav; 2007 Jan; 86(1):140-9. PubMed ID: 17275894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methamphetamine-induced behavioural effects and brain concentrations of methamphetamine and its metabolite amphetamine in mice.
    Brien JF; Kitney JC; Peachey JE; Rogers BJ
    Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):313-28. PubMed ID: 569889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse.
    Cho AK; Melega WP; Kuczenski R; Segal DS
    Synapse; 2001 Feb; 39(2):161-6. PubMed ID: 11180503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detox agents do not affect the pharmacokinetics of methamphetamine in the rat.
    Lee SK; Kim Y; Suh S; Suh YJ; In MK; Kim DH; Jin C; Yoo HH
    Forensic Sci Int; 2009 Apr; 186(1-3):e21-4. PubMed ID: 19203851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methamphetamine blood concentrations in human abusers: application to pharmacokinetic modeling.
    Melega WP; Cho AK; Harvey D; Laćan G
    Synapse; 2007 Apr; 61(4):216-20. PubMed ID: 17230548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of tolerance to methamphetamine-induced monoamine deficits.
    Danaceau JP; Deering CE; Day JE; Smeal SJ; Johnson-Davis KL; Fleckenstein AE; Wilkins DG
    Eur J Pharmacol; 2007 Mar; 559(1):46-54. PubMed ID: 17239369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human pharmacology of the methamphetamine stereoisomers.
    Mendelson J; Uemura N; Harris D; Nath RP; Fernandez E; Jacob P; Everhart ET; Jones RT
    Clin Pharmacol Ther; 2006 Oct; 80(4):403-20. PubMed ID: 17015058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a home cage locomotor tracking system capable of detecting the stimulant and sedative properties of drugs in rats.
    Dunne F; O'Halloran A; Kelly JP
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1456-63. PubMed ID: 17706334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of anti-(+)-methamphetamine monoclonal antibody to significantly alter (+)-methamphetamine and (+)-amphetamine disposition in rats.
    Laurenzana EM; Byrnes-Blake KA; Milesi-Hallé A; Gentry WB; Williams DK; Owens SM
    Drug Metab Dispos; 2003 Nov; 31(11):1320-6. PubMed ID: 14570763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
    Bjorklund NL; Sorg BA; Schenk JO
    Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.